Santica M Marcovina Selected Research

Metformin (Glucophage)

1/2019	Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
12/2016	Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.
1/2016	Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santica M Marcovina Research Topics

Disease

37	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 07/2002
24	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024 - 04/2006
23	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2002
12	Atherosclerosis 01/2022 - 12/2002
11	Coronary Disease (Coronary Heart Disease) 05/2018 - 08/2002
10	Insulin Resistance 05/2023 - 12/2006
10	Thrombosis (Thrombus) 01/2022 - 06/2003
9	Inflammation (Inflammations) 01/2022 - 06/2010
8	Obesity 01/2024 - 01/2009
7	Myocardial Infarction 11/2019 - 06/2005
6	Stroke (Strokes) 11/2019 - 06/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2018 - 10/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 04/2014 - 11/2003
5	Genetic Risk Score 01/2024 - 12/2016
5	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 10/2015
5	Ischemic Stroke 05/2018 - 04/2004
4	Kidney Diseases (Kidney Disease) 05/2023 - 12/2002
4	Hypoglycemia (Reactive Hypoglycemia) 11/2022 - 02/2016
4	Dyslipidemias (Dyslipidemia) 01/2020 - 09/2010
4	Vascular Diseases (Vascular Disease) 01/2018 - 04/2004
4	Alzheimer Disease (Alzheimer's Disease) 12/2013 - 05/2005
4	Chronic Renal Insufficiency 08/2005 - 12/2002
3	Diabetes Complications 01/2023 - 03/2009
3	Hypertension (High Blood Pressure) 01/2020 - 04/2007
3	Acute Coronary Syndrome 05/2018 - 09/2002
3	Overweight 01/2016 - 03/2009
3	Renal Insufficiency (Renal Failure) 08/2005 - 03/2002
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 12/2002
2	Chronic Disease (Chronic Diseases) 01/2023 - 02/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2017
2	Diabetes Mellitus 01/2019 - 08/2017
2	Glucose Intolerance 01/2019 - 01/2016
2	Pathologic Constriction (Stenosis) 04/2014 - 01/2013
2	Heart Failure 07/2012 - 11/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2010 - 04/2004
2	Hypercholesterolemia 04/2007 - 12/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2003 - 11/2002
1	Albuminuria 05/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2022
1	Long Term Adverse Effects 01/2022
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

41	Lipoprotein(a)IBA 12/2023 - 03/2002
22	Apolipoproteins AIBA 01/2022 - 03/2002
16	LipidsIBA 12/2022 - 11/2002
15	Apoprotein(a) (Apolipoprotein (a))IBA 01/2021 - 03/2002
11	Lipoproteins (Lipoprotein)IBA 01/2022 - 07/2003
10	Insulin (Novolin)FDA Link 01/2023 - 01/2008
10	LDL CholesterolIBA 12/2022 - 11/2002
10	Triglycerides (Triacylglycerol)IBA 05/2018 - 01/2005
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 09/2002
9	C-Reactive ProteinIBA 11/2019 - 09/2002
9	oxidized low density lipoproteinIBA 01/2018 - 12/2006
9	Protein Isoforms (Isoforms)IBA 05/2013 - 03/2002
8	Biomarkers (Surrogate Marker)IBA 05/2023 - 03/2012
7	LDL Lipoproteins (beta Lipoproteins)IBA 12/2022 - 12/2006
7	Apolipoproteins B (ApoB)IBA 01/2022 - 12/2006
7	ApolipoproteinsIBA 01/2017 - 05/2005
6	HDL CholesterolIBA 01/2024 - 01/2009
6	AutoantibodiesIBA 01/2024 - 07/2011
6	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2019 - 10/2013
5	AlbuminsIBA 05/2023 - 07/2003
5	CholesterolIBA 01/2016 - 11/2003
5	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 12/2006
4	C-PeptideIBA 01/2024 - 03/2015
4	CreatinineIBA 01/2024 - 10/2007
4	LeptinIBA 01/2022 - 12/2002
4	Fibrinogen (Factor I)FDA Link 11/2019 - 06/2010
3	Interleukin-6 (Interleukin 6)IBA 11/2019 - 06/2010
3	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2016
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 06/2010
3	Glucagon (Glukagon)FDA Link 10/2016 - 02/2016
2	CalciumIBA 01/2023 - 12/2002
2	Simvastatin (Zocor)FDA LinkGeneric 11/2019 - 03/2018
2	AdiponectinIBA 11/2018 - 12/2011
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 10/2011
2	Apolipoprotein B-100 (Apo B 100)IBA 04/2016 - 04/2009
2	1-penicillamyl-Leu(2)- oxytocinIBA 07/2015 - 04/2009
2	Glycoproteins (Glycoprotein)IBA 07/2009 - 07/2003
2	Phospholipids (Phosphatides)FDA LinkGeneric 04/2009 - 05/2005
2	low density lipoprotein inhibitorIBA 03/2008 - 11/2002
2	AutoantigensIBA 10/2007 - 04/2006
2	Glutamic Acid (Glutamate)FDA Link 10/2007 - 04/2006
2	Rosiglitazone (Avandia)FDA Link 12/2006 - 11/2002
2	Serum AlbuminIBA 08/2005 - 01/2005
1	SphingolipidsIBA 01/2024
1	E-SelectinIBA 05/2023
1	ProinsulinIBA 05/2023
1	SodiumIBA 01/2023
1	MagnesiumIBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Vitamin E FDA LinkGeneric 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	CytokinesIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Fibric Acids (Fibrates)IBA 01/2020

Therapy/Procedure

14	Therapeutics 01/2021 - 11/2002
11	Glycemic Control 11/2022 - 11/2002
1	Patient Transfer (Patient Dumping) 01/2023
1	Ligation 01/2022
1	Tertiary Prevention 01/2021